Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Besterman

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
European Heart Journal|July 1, 1983
How disturbing are side effects of beta blockersE M Besterman
The West Indian Medical Journal|January 5, 2002
Some notes on the history of rheumatic carditisE M Besterman
The Practitioner|March 1, 1982
Changes in cardiological practice over the past eighteen yearsE M Besterman
Atherosclerosis|July 1, 1970
Effects of laminarin sulphate on experimental atherosclerosis and on serum lipids in rabbits during long-term intermittent cholesterol feedingE M Besterman
Atherosclerosis|July 1, 1970
Experimental coronary atherosclerosis in rabbitsE M Besterman
British Journal of Clinical Pharmacology|January 1, 1979
Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patientsE M Besterman, M Spencer
British Journal of Clinical Pharmacology|December 5, 2015
Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patientsE M Besterman, M Spencer
Lancet (London, England)|August 5, 1972
Heparin effects on irreversible platelet aggregationE M Besterman, M P Gillett
Postgraduate Medical Journal|August 1, 1976
An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectorisM B Comerford, E M Besterman
Atherosclerosis|July 1, 1975
Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseasesM P Gillett, E M Besterman
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
European Heart Journal|July 1, 1983
How disturbing are side effects of beta blockersE M Besterman
The West Indian Medical Journal|January 5, 2002
Some notes on the history of rheumatic carditisE M Besterman
The Practitioner|March 1, 1982
Changes in cardiological practice over the past eighteen yearsE M Besterman
Atherosclerosis|July 1, 1970
Effects of laminarin sulphate on experimental atherosclerosis and on serum lipids in rabbits during long-term intermittent cholesterol feedingE M Besterman
Atherosclerosis|July 1, 1970
Experimental coronary atherosclerosis in rabbitsE M Besterman
British Journal of Clinical Pharmacology|January 1, 1979
Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patientsE M Besterman, M Spencer
British Journal of Clinical Pharmacology|December 5, 2015
Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patientsE M Besterman, M Spencer
Lancet (London, England)|August 5, 1972
Heparin effects on irreversible platelet aggregationE M Besterman, M P Gillett
Postgraduate Medical Journal|August 1, 1976
An eighteen months' study of the clinical response to metoprolol, a selective beta1-receptor blocking agent, in patients with angina pectorisM B Comerford, E M Besterman
Atherosclerosis|July 1, 1975
Plasma concentrations of lysolecithin and other phospholipids in the healthy population and in men suffering from atherosclerotic diseasesM P Gillett, E M Besterman
Pageof 4